.Merck defeats incomes expectations, raises sales outlook on solid need for best medications like Keytruda CNBCMerck & Co. (MRK US) Trumps Revenue Projections as Keytruda Purchases Surge BloombergMerck Supply: Pharma Titan Posts Strong Results, But Outlook Drops Short Financier's Company DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck beats revenue and purchases assumptions amid Keytruda strong point, however provides combined full-year expectation MarketWatch.